Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
Objective of the study: To test the efficacy of theta burst cerebellar stimulation on dual task walking in Parkinson's disease using a cross-over design and wearing sensors technology Design: Twenty Parkinson's disease patients with no dementia will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days. Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 18, 2020
CompletedFirst Posted
Study publicly available on registry
January 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJanuary 23, 2020
January 1, 2020
2.2 years
January 18, 2020
January 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Step variability in dual-task walking
Step variability will be assessed in normal, cognitive/motor dual-task conditions walking
Changes from Baseline to immediately after stimulation
Step length in dual-task walking
Step length will be assessed in normal, cognitive/motor dual-task conditions
Changes from Baseline to immediately after stimulation
Gait speed in dual-task walking
Gait speed will be assessed in normal, cognitive/motor dual-task conditions
Changes from Baseline to immediately after stimulation
Secondary Outcomes (2)
Turning speed in timed up and go tests
Changes from Baseline to immediately after stimulation
total distance of dual-task walking
Changes from Baseline to immediately after stimulation
Study Arms (2)
Real Stimulation
ACTIVE COMPARATORCerebellar Repetitive theta burst stimulation will be performed using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.
Sham Stimulation
PLACEBO COMPARATORThe rTMS coil stimulation will be applied in the same position of the real stimulation. The Stimulation will be performed like in the real arm with the difference that the coil will be masked and thus will be inactive. The patient will hear the same sound of real stimulation, which will be only functionally inactive but will be completely performed (for the whole time of duration of stimulation)
Interventions
Cerebellar repetitive theta Burst stimulation will be performed as detailed in the Real arm description
Eligibility Criteria
You may qualify if:
- established Parkinson's disease
- ability to stand alone and walk without support
You may not qualify if:
- dementia or behavioral alterations
- contraindication to stimulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Europea di Ricerca Biomedica Ferb Onluslead
- University of Kielcollaborator
- Università degli Studi di Bresciacollaborator
Study Sites (1)
Parkinson's disease Rehabilitation Centre - FERB ONLUS
Trescore Balneario, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Pilotto, MD
FERB Onlus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The patient and the examiner who administered the clinical scales were blind to the type of rTMS delivered, which was applied by another blinded experimenter.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Parkinson's disease Rehabilitation Centre
Study Record Dates
First Submitted
January 18, 2020
First Posted
January 23, 2020
Study Start
January 1, 2018
Primary Completion
April 1, 2020
Study Completion
June 1, 2020
Last Updated
January 23, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- In the publication, within the next year
- Access Criteria
- on line availability
The whole study will be published in medical journal